Agreement signedAgreed 24 Oct 2025

Eli Lilly and Company /
Adverum Biotechnologies, Inc.

Eli Lilly and Company agrees to buy Adverum Biotechnologies, Inc.

Buy side: Eli Lilly and Company
Buy sideEli Lilly and Company
Target: Adverum Biotechnologies, Inc.
TargetAdverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. · 24 Oct 2025Source
Buy side: Eli Lilly and Company
Buy sideEli Lilly and Company
Target: Adverum Biotechnologies, Inc.
TargetAdverum Biotechnologies, Inc.
01 / BuyerEli Lilly and Company
02 / TargetAdverum Biotechnologies, Inc.
Source for the buyer and target: Adverum Biotechnologies, Inc.

For the buyer and target.

“As previously disclosed in its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 24, 2025, Adverum Biotechnologies, Inc., a Delaware corporation (“Adverum” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 24, 2025, by and among the Company, Eli Lilly and Company, an Indiana corporation (“Parent”), and Flying Tigers Acquisition Corporation, a Delaware corporation and direct wholly owned subsidiary of Parent (“Purchaser”).”

Published 9 Dec 2025

Open the source
01

What happened

Eli Lilly and Company agreed to acquire Adverum Biotechnologies, Inc., according to a filing dated Dec. 9, 2025. [01]

02

Who is involved, and the source

Everything on this page comes from the source below, quoted word for word.

Advisers

Target

Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.

01
Source · Adverum Biotechnologies, Inc.

Eli Lilly and Company agrees to buy Adverum Biotechnologies, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Adverum Biotechnologies, Inc.

    The source this page is built from.

    Open the source
  2. Announced

    “Eli Lilly and Company agrees to buy Adverum Biotechnologies, Inc. Eli Lilly and Company agreed to acquire Adverum Biotechnologies, Inc., according to a filing dated Dec. 9, 2025”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.